ABOS Acumen Pharmaceuticals, Inc. - Common Stock
$2,23
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 12, 2026
Zakres 52 tyg.
$1–$4
48% of range
Ocena Analityków
STRONG BUY
12 analysts
Cena Docelowa
$7
+232% upside
P/E (TTM)
-1.1
ROE
-129.4%
Marża Zysku Netto
—
ABOS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$2.23
Kapitalizacja Rynkowa
$128M
P/E (TTM)
-1.1
EPS (TTM)
$-2.00
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-129.4%
D/E Dług/Kapitał
0.1
Zakres 52 tyg.
$1 – $4
ABOS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
EPS
$-2.00
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-116M
2021-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
ABOS
Mediana porównawcza
P/E (TTM)
-1.1
16.5
P/B
1.8
2.2
EV / EBITDA
-0.2
—
Price / FCF (Cena / FCF)
-1.1
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
ABOS
Mediana porównawcza
ROA
-67.1%
-65.8%
ROE
-129.4%
-80.6%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
ABOS
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.1
216.2
Current Ratio (Wskaźnik bieżący)
4.1
3.7
Quick Ratio (Wskaźnik Szybkości)
3.9
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
ABOS
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
ABOS
Mediana porównawcza
ABOS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
12 analityków
- Mocne kupno 6 50,0%
- Kup 5 41,7%
- Trzymaj 1 8,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
5 analityków · 2026-05-15
Mediana
$8.00
Średnia
$7.40
← Poniżej wszystkich celów
$2.23
Niski
$4.00
Wysoki
$10.00
Średni cel
$8.00
+258,7%
Średnia cel
$7.40
+231,8%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.04%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.33 | $-0.41 | 0.08% |
| 31 grudnia 2025 | $-0.41 | $-0.46 | 0.05% |
| 30 września 2025 | $-0.44 | $-0.62 | 0.18% |
| 30 czerwca 2025 | $-0.68 | $-0.55 | -0.13% |
| 31 marca 2025 | $-0.48 | $-0.68 | 0.20% |
| 31 grudnia 2024 | $-0.62 | $-0.49 | -0.13% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | — |
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| HURA | — | -1.2 | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $105M | $94M | $42M | $32M | $12M | $8M | |
| SG&A Expense | $19M | $20M | $19M | $13M | $7M | $1M | |
| Operating Expenses | $124M | $114M | $61M | $45M | $20M | $9M | |
| Operating Income | $-124M | $-114M | $-61M | $-45M | $-20M | $-8M | |
| Interest Expense | · | · | $581.0K | $0 | · | · | |
| Interest Income | $7M | $14M | $11M | $2M | · | · | |
| Other Non-op | $-266.0K | $-151.0K | $-83.0K | $-11.0K | $51.0K | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-121M | $-102M | $-52M | $-43M | $-101M | $-7M | |
| EPS (Basic) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · | |
| EPS (Diluted) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · | |
| Shares (Basic) | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · | |
| Shares (Diluted) | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · | |
| EBITDA | $-124M | $-114M | $-61M | $-45M | $-20M | · |
Bilans 25
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $36M | $67M | $130M | $122M | $44M | |
| Short-term Investments | $63M | $136M | $177M | $48M | $72M | · | |
| Prepaid Expense | $5M | $7M | $3M | $3M | $4M | $543.0K | |
| Other Current Assets | · | · | $283.0K | $237.0K | $140.0K | · | |
| Current Assets | $122M | $178M | $247M | $180M | $199M | $44M | |
| PP&E (Net) | $103.0K | $73.0K | $122.0K | $165.0K | $36.0K | · | |
| Accum. Depreciation | $200.0K | $100.0K | $100.0K | · | · | · | |
| Other Non-current Assets | $350.0K | $486.0K | $724.0K | $151.0K | $14.0K | $0 | |
| Total Assets | $123M | $239M | $310M | $197M | $230M | $44M | |
| Accounts Payable | $554.0K | $6M | $1M | $2M | $1M | $531.0K | |
| Accrued Liabilities | $10M | $7M | $6M | $3M | · | · | |
| Short-term Debt | $9M | $0 | · | · | · | · | |
| Current Liabilities | $30M | $28M | $13M | $8M | $5M | · | |
| Capital Leases | · | $150.0K | $284.0K | $0 | · | · | |
| Other Non-current Liabilities | $0 | $150.0K | $284.0K | · | · | · | |
| Total Liabilities | $52M | $57M | $43M | $8M | $5M | $6M | |
| Long-term Debt | $22M | $29M | $30M | $0 | · | · | |
| Total Debt | $9M | · | · | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | · | |
| Paid-in Capital | $517M | $507M | $489M | $360M | $353M | $8M | |
| Retained Earnings | $-446M | $-325M | $-223M | $-170M | $-128M | $-27M | |
| AOCI | $83.0K | $-48.0K | $312.0K | $-751.0K | · | · | |
| Stockholders' Equity | $70M | $182M | $267M | $189M | $225M | $-19M | |
| Liabilities + Equity | $123M | $239M | $310M | $197M | $230M | $44M | |
| Shares Outstanding | 60,575,369 | 60,094,083 | 57,910,461 | 41,025,062 | 40,473,270 | 419,124 |
Przepływy pieniężne 9
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $6M | $3M | $922.0K | $154.0K | |
| Operating Cash Flow | $-116M | $-86M | $-43M | $-35M | $-18M | $-7M | |
| CapEx | $88.0K | $16.0K | $21.0K | $161.0K | $40.0K | · | |
| Investing Cash Flow | $134M | $48M | $-172M | $39M | $-104M | · | |
| Stock Issued | $0 | $8M | $122M | $4M | $169M | · | |
| Net Stock Activity | $0 | $8M | $122M | $4M | $169M | · | |
| Financing Cash Flow | $-34.0K | $7M | $152M | $4M | $200M | $45M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-116M | $-86M | $-43M | $-35M | $-18M | · |
Rentowność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -67.1% | -37.3% | -20.7% | -20.1% | -73.2% | · | |
| ROE | -129.4% | -51.3% | -19.1% | -22.2% | -43.9% | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 6.5 | 19.0 | 23.1 | · | · | |
| Quick Ratio | 3.9 | 6.2 | 18.8 | 6.1 | · | · | |
| Debt / Equity | 0.1 | · | · | · | · | · | |
| Interest Coverage | · | · | -105.2 | · | · | · |
Wycena (TTM) 11
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-121M | $-102M | $-52M | $-43M | $-101M | · | |
| Market Cap | $128M | $103M | $222M | $222M | $274M | · | |
| Enterprise Value | $20M | · | · | · | · | · | |
| P/E | -1.1 | -1.0 | -3.6 | -5.1 | -1.3 | · | |
| P/B | 1.8 | 0.6 | 0.8 | 1.2 | 1.2 | · | |
| P / Tangible Book | 1.8 | 0.6 | 0.8 | 1.2 | 1.2 | · | |
| P / Cash Flow | -1.1 | -1.2 | -5.2 | -6.3 | -15.2 | · | |
| P / FCF | -1.1 | -1.2 | -5.2 | -6.3 | -15.2 | · | |
| EV / EBITDA | -0.2 | · | · | · | · | · | |
| EV / FCF | -0.2 | · | · | · | · | · | |
| Earnings Yield | -94.8% | -99.4% | -28.1% | -19.6% | -74.3% | · |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $16M | $21M | $22M | $37M | $25M | $35M | $27M | $20M | $12M | $13M | $11M | $9M | $9M | $11M | $8M | $7M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $21M | $25M | $27M | $42M | $30M | $40M | $32M | $24M | $18M | $18M | $16M | $13M | $13M | $14M | $11M | $10M | |
| Operating Income | $-21M | $-25M | $-27M | $-42M | $-30M | $-40M | $-32M | $-24M | $-18M | $-18M | $-16M | $-13M | $-13M | $-14M | $-11M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1M | · | · | · | $0 | · | · | · | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | · | · | · | |
| Other Non-op | $-43.0K | $-4.0K | $-69.0K | $-129.0K | $-64.0K | $-62.0K | $33.0K | $-68.0K | $-54.0K | $-21.0K | $-42.0K | $-16.0K | $-4.0K | $-10.0K | $-2.0K | $0 | |
| Net Income | $-21M | $-25M | $-26M | $-41M | $-29M | $-37M | $-30M | $-21M | $-15M | $-16M | $-13M | $-12M | $-11M | $-13M | $-11M | $-10M | |
| EPS (Basic) | $-0.33 | $-0.40 | $-0.44 | $-0.68 | $-0.48 | $-0.62 | $-0.50 | $-0.34 | $-0.25 | $-0.28 | $-0.24 | $-0.28 | $-0.28 | $-0.32 | $-0.26 | $-0.25 | |
| EPS (Diluted) | $-0.33 | $-0.40 | $-0.44 | $-0.68 | $-0.48 | $-0.62 | $-0.50 | $-0.34 | $-0.25 | $-0.28 | $-0.24 | $-0.28 | $-0.28 | $-0.32 | $-0.26 | $-0.25 | |
| Shares (Basic) | 63,219,289 | -121,110,642 | 60,573,425 | 60,573,425 | 60,525,628 | -119,958,279 | 60,079,778 | 60,079,778 | 59,812,000 | -87,670,371 | 54,229,630 | 41,025,062 | 41,025,062 | -80,871,281 | 40,502,860 | 40,497,087 | |
| Shares (Diluted) | 63,219,289 | -121,110,642 | 60,573,425 | 60,573,425 | 60,525,628 | -119,958,279 | 60,079,778 | 60,079,778 | 59,812,000 | -87,670,371 | 54,229,630 | 41,025,062 | 41,025,062 | -80,871,281 | 40,502,860 | 40,497,087 | |
| EBITDA | $-21M | · | $-27M | $-42M | $-30M | · | $-32M | $-24M | $-18M | · | $-16M | $-13M | $-13M | · | $-11M | $-10M |
Bilans 25
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $54M | $47M | $37M | $30M | $36M | $33M | $68M | $47M | $67M | $95M | · | · | $130M | $158M | $111M | |
| Short-term Investments | $77M | $63M | $80M | $107M | $119M | $136M | $167M | $193M | $206M | $177M | $121M | $68M | $62M | $48M | $43M | $79M | |
| Prepaid Expense | $5M | $5M | $6M | $5M | $6M | $7M | $7M | $6M | $3M | $3M | $3M | $5M | $4M | $3M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | $457.0K | $405.0K | $395.0K | · | $181.0K | $208.0K | $294.0K | $237.0K | · | · | |
| Current Assets | $133M | $122M | $132M | $148M | $155M | $178M | $208M | $267M | $256M | $247M | $219M | $150M | $144M | $180M | $203M | $191M | |
| PP&E (Net) | $91.0K | $103.0K | $115.0K | $130.0K | $137.0K | $73.0K | $89.0K | $105.0K | $117.0K | $122.0K | $123.0K | $136.0K | $151.0K | · | $142.0K | $113.0K | |
| Accum. Depreciation | $200.0K | $200.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | · | · | $100.0K | · | · | · | · | · | · | |
| Other Non-current Assets | $304.0K | $350.0K | $393.0K | $464.0K | $504.0K | $486.0K | $170.0K | $425.0K | $324.0K | $724.0K | $189.0K | $208.0K | $195.0K | $151.0K | $92.0K | $106.0K | |
| Total Assets | $134M | $123M | $142M | $172M | $204M | $239M | $267M | $289M | $301M | $310M | $286M | $177M | $188M | $197M | $203M | $212M | |
| Accounts Payable | $2M | $554.0K | $682.0K | $2M | $1M | $6M | $2M | $4M | $3M | $1M | $1M | $2M | $762.0K | $2M | $2M | $2M | |
| Accrued Liabilities | $5M | $10M | $8M | $12M | $7M | $7M | $5M | $4M | $3M | $6M | $3M | $2M | · | $3M | · | · | |
| Short-term Debt | $14M | $9M | $4M | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $29M | $30M | $22M | $25M | $19M | $28M | $20M | $15M | $8M | $13M | $6M | $9M | $9M | $8M | $7M | $5M | |
| Capital Leases | · | · | $39.0K | $77.0K | $114.0K | $150.0K | $185.0K | $219.0K | $252.0K | $284.0K | · | · | · | $0 | · | $25.0K | |
| Other Non-current Liabilities | · | $0 | $39.0K | $77.0K | $114.0K | $150.0K | · | · | · | $284.0K | · | · | · | · | · | · | |
| Total Liabilities | $46M | $52M | $49M | $55M | $49M | $57M | $50M | $45M | $39M | $43M | $6M | $9M | $9M | $8M | $7M | $5M | |
| Long-term Debt | $17M | $22M | $27M | $30M | $30M | $29M | $30M | $29M | $30M | $30M | · | · | · | $0 | · | · | |
| Total Debt | $14M | · | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $555M | $517M | $514M | $512M | $509M | $507M | $505M | $502M | $500M | $489M | $487M | $363M | $361M | $360M | $355M | $354M | |
| Retained Earnings | $-467M | $-446M | $-421M | $-395M | $-354M | $-325M | $-288M | $-258M | $-238M | $-223M | $-206M | $-193M | $-182M | $-170M | $-158M | $-147M | |
| AOCI | $21.0K | $83.0K | $109.0K | $23.0K | $15.0K | $-48.0K | $518.0K | $-164.0K | $-144.0K | $312.0K | $-509.0K | $-646.0K | · | $-751.0K | · | · | |
| Stockholders' Equity | $87M | $70M | $93M | $117M | $156M | $182M | $217M | $244M | $262M | $267M | $280M | $169M | $179M | $189M | $197M | $207M | |
| Liabilities + Equity | $134M | $123M | $142M | $172M | $204M | $239M | $267M | $289M | $301M | $310M | $286M | $177M | $188M | $197M | $203M | $212M | |
| Shares Outstanding | 72,227,580 | 60,575,369 | 60,573,425 | 60,573,425 | 60,573,425 | 60,094,083 | 60,079,778 | 60,079,778 | 60,079,778 | 57,910,461 | 57,910,461 | 41,025,062 | 41,025,062 | 41,025,062 | 40,503,124 | 40,501,258 |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $888.0K | $840.0K | $715.0K | |
| Operating Cash Flow | $-24M | $-19M | $-30M | $-32M | $-34M | $-27M | $-25M | $-17M | $-18M | $-8M | $-13M | $-12M | $-10M | $-11M | $-9M | $-6M | |
| CapEx | $0 | $0 | $0 | $9.0K | $79.0K | $0 | $0 | $5.0K | $11.0K | $14.0K | $7.0K | $0 | $0 | $35.0K | $81.0K | $36.0K | |
| Investing Cash Flow | $-14M | $26M | $41M | $38M | $29M | $30M | $-10M | $38M | $-9M | $-49M | $-92M | $11M | $-42M | $-20M | $56M | $9M | |
| Stock Issued | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $8M | $-390.0K | $122M | $0 | $0 | $4M | · | · | |
| Net Stock Activity | · | · | · | · | $0 | · | · | · | $8M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $36M | $2.0K | $0 | $0 | $-36.0K | $-9.0K | $-42.0K | $-128.0K | $7M | $29M | $123M | $-145.0K | $0 | $4M | $-263.0K | · | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-24M | · | · | · | $-34M | · | · | · | $-18M | · | · | · | $-10M | · | · | · |
Rentowność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.3% | · | -12.9% | -17.8% | -11.4% | · | -10.8% | -8.8% | -6.1% | · | -5.3% | -6.0% | -5.5% | · | -4.9% | -7.1% | |
| ROE | -17.1% | · | -17.0% | -22.7% | -13.8% | · | -12.0% | -10.0% | -6.7% | · | -5.4% | -6.2% | -5.7% | · | -5.0% | -20.2% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | · | 6.0 | 6.0 | 8.0 | · | 10.4 | 17.4 | 30.2 | · | 35.8 | 17.5 | 16.4 | · | 30.6 | 37.2 | |
| Quick Ratio | 4.4 | · | 5.8 | 5.8 | 7.7 | · | 10.1 | 17.0 | 29.8 | · | 35.3 | 7.9 | 7.1 | · | 30.3 | 37.0 | |
| Debt / Equity | 0.2 | · | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -17.8 | · | · | · | · | · | · | · |
Wycena (TTM) 11
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-117M | · | $-126M | $-120M | $-94M | · | $-78M | $-60M | $-51M | · | $-47M | $-44M | $-41M | · | $-34M | $-85M | |
| Market Cap | $170M | · | $104M | $70M | $67M | · | $149M | $145M | $243M | · | $240M | $197M | $167M | · | $406M | $190M | |
| Enterprise Value | $56M | · | $-19M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.2 | · | -0.8 | -0.6 | -0.7 | · | -1.9 | -2.2 | -3.9 | · | -3.9 | -4.5 | -4.0 | · | -11.9 | -0.0 | |
| P/B | 1.9 | · | 1.1 | 0.6 | 0.4 | · | 0.7 | 0.6 | 0.9 | · | 0.9 | 1.2 | 0.9 | · | 2.1 | 0.9 | |
| P / Tangible Book | 1.9 | · | 1.1 | 0.6 | 0.4 | · | 0.7 | 0.6 | 0.9 | · | 0.9 | 1.2 | 0.9 | · | 2.1 | 0.9 | |
| P / Cash Flow | -7.1 | · | · | · | -2.0 | · | · | · | -13.6 | · | · | · | -16.4 | · | · | · | |
| P / FCF | -7.1 | · | · | · | -1.9 | · | · | · | -13.6 | · | · | · | -16.4 | · | · | · | |
| EV / EBITDA | -2.7 | · | 0.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -2.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -81.8% | · | -122.8% | -172.4% | -142.7% | · | -53.6% | -45.9% | -25.9% | · | -25.5% | -22.2% | -25.1% | · | -8.4% | -3032.1% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Zysk netto | $-121M | $-102M | $-52M | $-43M | $-101M |
| Rozwodniony EPS | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.1 | — | — | — | — |
| Wskaźnik bieżący | 4.1 | 6.5 | 19.0 | 23.1 | — |
| Wskaźnik Szybkości | 3.9 | 6.2 | 18.8 | 6.1 | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-116M | $-86M | $-43M | $-35M | $-18M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.